April 29, 2016 8:52 AM ET

Life Sciences Tools and Services

Company Overview of NuGEN Technologies, Inc.

Company Overview

NuGEN Technologies, Inc. develops and commercializes technologies and products for accurate and targeted genomic analysis. The company offers DNA and RNA sample preparation products for use in research and diagnostic applications. It provides a portfolio of technologies to address microarray and Next-Gen Sequencing applications, including RNA-Seq, targeted resequencing of DNA and RNA, target capture, ChIP-Seq, and Methyl-Seq; sample preparation solutions for RNA and DNA that enable the analysis of specimens, which are limited or of poor quality on microarray and qPCR analysis platforms; and sample preparation solutions for high throughput applications, such as Next Gen Sequencing, microarray...

201 Industrial Road

Suite 310

San Carlos, CA 94070

United States

Founded in 2000

Phone:

650-590-3600

Fax:

650-590-3630

Key Executives for NuGEN Technologies, Inc.

Chief Executive Officer and Director
Age: 48
Chief Financial Officer
Senior Director of Product Marketing
Director of Technical Support
Director of Sales - Asia Pacific
Compensation as of Fiscal Year 2015.

NuGEN Technologies, Inc. Key Developments

NuGEN Technologies, Inc. Announces Commercial Introduction of Ovation SoLo RNA-Seq System

NuGEN Technologies, Inc. announced the launch of the Ovation SoLo RNA-Seq System, the company’s latest tool in its suite of sample preparation products supporting research in areas previously hampered by sample input limitations such as single cells and liquid biopsy. The Ovation SoLo kit will facilitate research in areas such as blood-borne biomarkers, cellular heterogeneity, and the study of single cell transcriptomics. Ovation SoLo provides a complete end-to-end solution for whole transcriptome analyses starting directly from cells or isolated RNA. The result is the most comprehensive cellular data and the best biology from the broadest range of input levels in samples with limited RNA quantity including single cell, liquid biopsy, and other low input RNA samples. The system features an improved method for ribosomal depletion of > 90%, efficient cDNA generation from ultra-low inputs that provides a complete representation of the entire transcriptome, and the capability to unambiguously identify PCR duplicates.

NuGEN Technologies Launches Enhanced Target Enrichment Technology Allowing More Comprehensive and Efficient NGS Analysis of Cancer Samples

NuGEN Technologies launched a sample preparation product that allows NGS detection of multiple changes in more than 500 individual genes implicated in cancer. The method can also be rapidly customized to provide target enrichment kits for any gene sets defined by the researcher within a target size range that may include thousands of genes or just a few. The new product is the new release in the company’s driveto offer tools for targeted resequencing that provide basic and clinical researchers with a holistic view of the underlying molecular biology of disease. Typically, to analyze single nucleotide mutations and copy number changes in a sample, researchers have had to employ completely different analysis platforms. NuGEN’s new method allows simultaneous targeted analysis of both types of changes, from a single sample preparation, on a choice of Illumina NGS systems.

PreAnalytiX GmbH, NuGEN Technologies and RUCDR Infinite Biologics Partner to Develop Clinically Validated RNA-Seq Workflow for Whole Blood Samples

PreAnalytiX GmbH, NuGEN Technologies, Inc. and RUCDR Infinite Biologics (RUCDR), announced a joint project to validate an end-to-end workflow for the reproducible collection and processing of whole blood for RNA sequencing (RNA-Seq) in clinical studies. The multi-site validation study involves three independent laboratories processing samples collected, stored and transported in the PAXgene Blood RNA System from PreAnalytiX to prepare strand-specific RNA-Seq libraries using NuGEN's Ovation Human Blood RNA-Seq System prior to NGS sequence analysis. RUCDR will oversee all sample collection, processing and data analysis for the purpose of validating the PreAnalytiX and NuGEN offerings in a combined workflow. Whole blood samples are used for a myriad of clinical genomics applications, due in part to the ease of collection as compared to other clinical sample types. However, there are challenges associated with preparation of human whole blood samples for analysis by RNA-Seq.

Similar Private Companies By Industry

Company Name Region
Wave Biotech, LLC United States
Physicians Clinical Research Solutions, Inc. United States
eGene, Inc. United States
Kalyra Pharmaceuticals, Inc. United States
Halloran Consulting Group, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NuGEN Technologies, Inc., please visit www.nugen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.